Prosight Management’s Neurocrine Biosciences NBIX Stock Holding History

Prosight Management’s Portfolio NBIX Stock Details NBIX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell
2024 Q3	$7.14M	Buy
2024 Q2	$3.72M	Sell
2024 Q1	$4.21M	Sell
2023 Q4	$4.73M	Sell
2023 Q3	$9M	Sell
2023 Q2	$16M	Buy
2023 Q1	$8.1M	Buy